V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20198001 | 20125672 | 1.53 | 65.5 | Palliative (P) | 2016-03-09 | 2016-05-09 | CETUXIMAB | 02 | N | CETUXIMAB | 100599661 |
| 20198003 | 20125673 | 0 | 92 | Palliative (P) | 2020-12-03 | 2021-02-17 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101369660 |
| 20198009 | 20125674 | 1.8 | 40.6 | Palliative (P) | 2017-08-27 | 2017-09-06 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101486321 |
| 20198017 | 20125675 | 1.75 | null | Palliative (P) | 2016-09-19 | 2016-10-04 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101243259 |
| 20198018 | 20125676 | 1.7 | 75 | Palliative (P) | 2018-10-26 | 2019-01-20 | CETUXIMAB | 02 | N | CETUXIMAB | 100764418 |
| 20198019 | 20125677 | 1.76 | 77.9 | Palliative (P) | 2018-01-29 | 2018-01-30 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101857712 |
| 20198021 | 20125678 | 1.65 | 87.05 | Palliative (P) | 2018-02-11 | 2018-06-20 | Cetuximab 7 day (>Cycle 2) | 02 | N | TRASTUZUMAB | 100421316 |
| 20198027 | 20125679 | 1.83 | 59.3 | Palliative (P) | 2018-04-26 | 2018-04-26 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100643608 |
| 20198029 | 20125680 | 1.76 | null | null | 2019-07-18 | 2019-07-20 | Trastuzumab | 02 | null | TRASTUZUMAB | 101538637 |
| 20198033 | 20125681 | 1.81 | 62.8 | Curative (C) | null | 2016-08-26 | Trastuzumab | null | null | TRASTUZUMAB | 100893657 |
| 20198034 | 20125682 | 1.8 | 46.6 | Curative (C) | null | 2019-10-06 | CETUXIMAB | 02 | null | CETUXIMAB | 101376301 |
| 20198035 | 20125683 | 1.83 | 73 | Curative (C) | 2017-03-18 | 2017-03-19 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101286579 |
| 20198037 | 20125684 | 1.77 | 88.5 | Palliative (P) | 2016-01-21 | 2016-02-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 100114900 |
| 20198039 | 20125685 | 1.69 | 64.5 | null | null | 2017-03-09 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100914155 |
| 20198040 | 20125686 | 1.82 | 56 | null | 2018-12-17 | 2018-12-24 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100370129 |
| 20198042 | 20125687 | 1.73 | 79.9 | Palliative (P) | 2017-12-28 | 2017-12-29 | CETUXIMAB | 2 | N | CETUXIMAB | 100069948 |
| 20198044 | 20125688 | 1.9 | 69.2 | Curative (C) | 2018-03-01 | 2018-04-26 | Cetuximab 7 day (Cycle 1) | null | N | TRASTUZUMAB | 101099298 |
| 20198047 | 20125689 | 1.72 | 78 | Palliative (P) | 2017-10-13 | 2017-10-13 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101611102 |
| 20198050 | 20125690 | 1.56 | 69 | null | 2020-02-12 | 2020-02-23 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101098462 |
| 20198051 | 20125691 | 0 | 87.6 | Palliative (P) | 2018-07-05 | 2018-07-13 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100550860 |
| 20198053 | 20125692 | 1.59 | 79.2 | null | 2018-07-30 | 2018-08-14 | CETUXIMAB | 2 | null | CETUXIMAB | 101520379 |
| 20198057 | 20125693 | 1.69 | 81.2 | null | 2018-02-20 | 2018-03-05 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101444849 |
| 20198062 | 20125694 | 1.88 | 70.3 | null | 2017-11-11 | 2017-11-17 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101460024 |
| 20198067 | 20125695 | 1.66 | 88 | 03 | 2018-05-12 | 2018-05-12 | Trastuzumab | 02 | Y | TRASTUZUMAB | 101379663 |
| 20198070 | 20125696 | 1.55 | 56.6 | Palliative (P) | 2016-05-11 | 2016-05-11 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101400803 |
| 20198075 | 20125697 | 1.75 | 86.4 | null | 2019-08-26 | 2019-09-18 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100388649 |
| 20198076 | 20125698 | 1.64 | 72.8 | Palliative (P) | 2019-07-22 | 2019-08-19 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100989718 |
| 20198082 | 20125699 | 1.58 | 91 | Adjuvant (A) | 2018-06-19 | 2018-06-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100245647 |
| 20198084 | 20125700 | 1.65 | 61.4 | Neo-adjuvant (N) | 2018-03-13 | 2018-03-13 | CETUXIMAB | 02 | N | CETUXIMAB | 100729459 |
| 20198085 | 20125701 | 1.8 | 60.9 | Palliative (P) | 2017-07-02 | 2017-10-19 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100463261 |
| 20198086 | 20125702 | 1.52 | 75 | Palliative (P) | 2018-09-23 | 2018-10-21 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100497239 |
| 20198089 | 20125703 | 1.51 | 90.6 | null | 2017-09-21 | 2017-10-05 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101694033 |
| 20198092 | 20125704 | 1.81 | 71.3 | Palliative (P) | 2016-11-24 | 2016-12-04 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101317593 |
| 20198109 | 20125705 | 1.78 | 78 | null | 2016-11-30 | 2017-03-08 | Trastuzumab 21 day loading dose | N | N | TRASTUZUMAB | 101302234 |
| 20198111 | 20125706 | 1.74 | null | null | 2020-04-13 | 2020-05-03 | Trastuzumab | 02 | N | TRASTUZUMAB | 100874308 |
| 20198112 | 20125707 | 1.72 | 60.8 | Palliative (P) | 2018-02-06 | 2018-03-12 | Trastuzumab | 02 | N | TRASTUZUMAB | 101450069 |
| 20198114 | 20125708 | 1.75 | 84.1 | Palliative (P) | 2017-09-09 | 2018-10-13 | CETUXIMAB | 02 | N | CETUXIMAB | 100805938 |
| 20198115 | 20125709 | 1.8 | null | Palliative (P) | 2016-06-09 | 2016-11-02 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101829115 |
| 20198116 | 20125710 | 1.71 | 95.7 | null | 2019-03-08 | 2019-03-08 | TRASTUZUMAB | null | null | TRASTUZUMAB | 101738696 |
| 20198119 | 20125711 | 1.8 | 69.3 | Neo-adjuvant (N) | 2020-11-15 | 2020-11-16 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100384373 |
| 20198124 | 20125712 | 1.65 | 59.1 | null | 2016-05-05 | 2019-09-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100899885 |
| 20198125 | 20125713 | 1.65 | 106 | Palliative (P) | null | 2020-01-28 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100972731 |
| 20198126 | 20125714 | 1.8 | 41 | Palliative (P) | 2018-11-25 | 2018-11-25 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100341536 |
| 20198127 | 20125715 | 1.65 | 53.7 | Curative (C) | 2020-03-11 | 2020-05-12 | Trastuzumab | N | N | TRASTUZUMAB | 100399574 |
| 20198131 | 20125716 | 1.73 | 80.6 | Palliative (P) | 2015-08-31 | 2016-04-03 | Trastuzumab | 02 | N | TRASTUZUMAB | 100664763 |
| 20198133 | 20125717 | 1.77 | 77 | null | null | 2019-11-17 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100526961 |
| 20198135 | 20125718 | 1.76 | 86 | Palliative (P) | 2019-09-24 | 2019-10-07 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 101608179 |
| 20198142 | 20125719 | 1.76 | 70.1 | Palliative (P) | 2017-02-14 | 2017-02-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 101632250 |
| 20198143 | 20125720 | 1.72 | 49 | null | 2017-06-17 | 2017-06-18 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100741322 |
| 20198144 | 20125721 | 1.74 | 66.5 | Palliative (P) | 2019-06-10 | 2019-06-15 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN | 101832331 |